Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2(EV) study
接受恩福妥单抗治疗的转移性尿路上皮癌患者的合并用药情况:来自 ARON-2(EV) 研究的真实世界数据
期刊:Clinical & Experimental Metastasis
影响因子:3.2
doi:10.1007/s10585-025-10335-4
Fiala, Ondřej; Buti, Sebastiano; Fujita, Kazutoshi; de Liaño, Alfonso Gómez; Fukuokaya, Wataru; Kimura, Takahiro; Yanagisawa, Takafumi; Giannatempo, Patrizia; Angel, Martin; Mennitto, Alessia; Molina-Cerrillo, Javier; Bourlon, Maria T; Soares, Andrey; Takeshita, Hideki; Calabrò, Fabio; Ortega, Cinzia; Kucharz, Jakub; Milella, Michele; Seront, Emmanuel; Park, Se Hoon; Tural, Deniz; Benedetti, Giovanni; Ürün, Yüksel; Battelli, Nicola; Melichar, Bohuslav; Poprach, Alexandr; Buchler, Tomas; Kopecký, Jindřich; Conteduca, Vincenza; Monteiro, Fernando Sabino Marques; Massari, Francesco; Gupta, Shilpa; Santoni, Matteo